Combination Chemotherapy, Total-Body Irradiation, and Alemtuzumab in Treating Patients Undergoing an Autologous Stem Cell Transplant for Stage I, Stage II, Stage III, or Stage IV Chronic Lymphocytic Leukemia

NCT00276809 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Chronic Lymphocytic Leukemia

Interventions

BIOLOGICAL: alemtuzumab
BIOLOGICAL: filgrastim
DRUG: carmustine
DRUG: cyclophosphamide
DRUG: cytarabine
DRUG: dexamethasone
DRUG: etoposide
DRUG: fludarabine phosphate
DRUG: melphalan
PROCEDURE: autologous bone marrow transplantation
PROCEDURE: peripheral blood stem cell transplantation
RADIATION: radiation therapy

Sponsor

German CLL Study Group